FN2 Earnings Intelligence
Bio-Techne Corporation income statement (quarterly)
Bio-Techne Corporation (TECH) Income Statement (quarterly) derived from persisted SEC financial facts.
Key Stats
USD in millions, except per-share values and percentages.
| Metric | 12/31/2024 | 3/31/2025 | 9/30/2025 | 12/31/2025 | 3/31/2026 | 6/30/2026 est. | 9/30/2026 est. |
|---|---|---|---|---|---|---|---|
| Market Cap | - | - | - | - | - | - | - |
| - Cash | $177.5 | $140.7 | $145 | $172.9 | $209.8 | - | - |
| + Debt | - | - | - | - | - | - | - |
| Enterprise Value | - | - | - | - | - | - | - |
| Revenue | $297 | $316.2 | $286.6 | $295.9 | $311.4 | $314.7 | $291.4 |
| % Growth | - | - | - | - | - | - | 1.7% |
| Gross Profit | $193.9 | $214.6 | $188.1 | $191.3 | $208.3 | - | - |
| % Margin | 65.3% | 67.9% | 65.6% | 64.6% | 66.9% | - | - |
| EBITDA | - | - | $72 | - | - | - | - |
| % Margin | - | - | 25.1% | - | - | - | - |
| Net Income | $34.9 | $22.6 | $38.2 | $38 | $51 | - | - |
| % Margin | 11.7% | 7.1% | 13.3% | 12.8% | 16.4% | - | - |
| Diluted EPS | $0.22 | $0.14 | $0.24 | $0.24 | $0.32 | $0.52 | $0.44 |
| % Growth | - | - | - | - | - | - | 83.7% |
| Operating Cash Flow | - | - | $27.6 | - | - | - | - |
| CapEx | - | - | $5.4 | - | - | - | - |
| Free Cash Flow | - | - | $22.2 | - | - | - | - |
Historical market capitalization is not persisted, so Market Cap and Enterprise Value remain unavailable rather than mixing today's market value into prior periods.
Income Statement
USD in millions, except per-share values and percentages.
| Metric | 12/31/2024 | 3/31/2025 | 9/30/2025 | 12/31/2025 | 3/31/2026 | 6/30/2026 est. | 9/30/2026 est. |
|---|---|---|---|---|---|---|---|
| Revenue | $297 | $316.2 | $286.6 | $295.9 | $311.4 | $314.7 | $291.4 |
| Gross Profit | $193.9 | $214.6 | $188.1 | $191.3 | $208.3 | - | - |
| EBITDA | - | - | $72 | - | - | - | - |
| Net Income | $34.9 | $22.6 | $38.2 | $38 | $51 | - | - |
| Diluted EPS | $0.22 | $0.14 | $0.24 | $0.24 | $0.32 | $0.52 | $0.44 |
Balance Sheet
USD in millions, except per-share values and percentages.
| Metric | 12/31/2024 | 3/31/2025 | 9/30/2025 | 12/31/2025 | 3/31/2026 |
|---|---|---|---|---|---|
| Cash & Equivalents | $177.5 | $140.7 | $145 | $172.9 | $209.8 |
| Short-term Debt | - | - | - | - | - |
| Long-term Debt | - | - | - | - | - |
| Total Debt | - | - | - | - | - |
Cash Flow
USD in millions, except per-share values and percentages.
| Metric | 12/31/2024 | 3/31/2025 | 9/30/2025 | 12/31/2025 | 3/31/2026 |
|---|---|---|---|---|---|
| Operating Cash Flow | - | - | $27.6 | - | - |
| Capital Expenditure | - | - | $5.4 | - | - |
| Free Cash Flow | - | - | $22.2 | - | - |
Ratios
USD in millions, except per-share values and percentages.
| Metric | 12/31/2024 | 3/31/2025 | 9/30/2025 | 12/31/2025 | 3/31/2026 |
|---|---|---|---|---|---|
| Revenue Growth | - | - | - | - | - |
| Gross Margin | 65.3% | 67.9% | 65.6% | 64.6% | 66.9% |
| EBITDA Margin | - | - | 25.1% | - | - |
| Net Margin | 11.7% | 7.1% | 13.3% | 12.8% | 16.4% |
| FCF Margin | - | - | 7.8% | - | - |
| Diluted EPS Growth | - | - | - | - | - |